View Author
scopus: 6701762937

Guetens, G.

(Gunther Guetens)


melphalan tumor perfusion patient hepatic liver response il -2 cancer treatment concentration metastase study hepatic perfusion limb perfusion colorectal effect catheter hypoxic hepatic perfusion toxicity necrosis leakage hepatic artery tumor necrosis factor artery portal vein portal tissue huvec result oncol response rates minute eggermont balloon netherland survival month growth technique histamine combination van tiel st evect control hepatic metastases disease bile duct necrosis melanoma sarcoma procedure uptake hypoxic tumor response factor volume muscle medium increase caval permeability circuit irresectable liver metastases libutti sk method group model -175 vessel assay 30 minutes tumor cells grade colorectal cancer operation irresectable liver metastases cancer institute value infusion




4 Most Recent Publications

Isolated hypoxic hepatic perfusion with retrograde outflow in patients with irresectable liver metastases; a new simplified technique in isolated hepatic perfusion (Article)
Verhoef, C. Wilt, J.H.W. de Brunstein, F. Marinelli, A.W. Etten, B. van Vermaas, M. Guetens, G. Boeck, G. de Bruijn, E.A. de Eggermont, A.M.M.
2008-05-01
Decreased response rates by the combination of histamine and IL-2 in melphalan-based isolated limb perfusion (Article)
Brunstein, F. Hoving, S. Aan de Wiel-Ambagtsheer, G. Bruijn, E.A. de Guetens, G. Eggermont, A.M.M. Hagen, T.L.M. ten
2007-04-01
Isolated hypoxic hepatic perfusion with orthograde or retrograde flow in patients with irresectable liver metastases using percutaneous balloon catheter techniques: a phase I and II study. (Article)
Etten, B. van Brunstein, F. Verhoef, C. IJken, M.G.A. van Marinelli, A.W. Sijp, J.R. van der Guetens, G. Boeck, G. de Bruijn, E.A. de Wilt, J.H.W. de Eggermont, A.M.M.
2004-12-01
Synergistic antitumor activity of histamine plus melphalan in isolated limb perfusion: preclinical studies. (Article)
Brunstein, F. Hoving, S. Seynhaeve, A.L.B. Tiel, S.T. van Guetens, G. Bruijn, E.A. de Eggermont, A.M.M. Hagen, T.L.M. ten
2004-11-03